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Abstract
Background: The evaluation of the hepatic parenchyma in patients with chronic liver disease is important to
assess the extension, localization and relationship with adjacent anatomical structures of possible lesions. This is
usually performed with conventional abdominal ultrasound, CT-scan or magnetic resonance imaging. In this
context, the feasibility and the safety of intravascular ultrasound in the liver have not been assessed yet.
Methods: We tested the safety and performance of an intracardiac echography (ICE) catheter applied by a
transjugular approach into the hepatic veins in patients with chronic liver disease undergoing hepatic
hemodynamic measurements.
Results: Five patients were enrolled in this pilot study. The insertion of the ICE catheter was possible into the right
and middle, but not into the left hepatic vein. The position of the ICE was followed using fluoroscopy and external
conventional ultrasound. Accurate imaging of focal hepatic parenchymal lesions, Doppler ultrasound of
surrounding blood vessels and assessment of liver surface and ascites were achieved without complications.
Conclusions: This study demonstrated that a diagnostic approach using an ICE device inserted in the hepatic
veins is feasible, safe and well tolerated. However, it remains for the moment only an experimental investigative
tool. Whether ICE adds further information regarding parenchymal lesions and associated vascular alterations as
compared to other techniques, needs additional investigation.
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Background
Assessment of disease extent is an important process in
the management of patients with chronic liver disease
and suspected parenchymal or vascular lesions [1-3].
The spatial relationship between lesions and their sur-
rounding anatomical structures - portal vein branches,
hepatic veins, bile ducts and liver capsule - is of particu-
lar importance for prognosis and choice of treatment.
For instance in hepatocellular carcinoma (HCC), the
size and the number of lesions represent the most criti-
cal information, impacting therapeutic options, that
include surgical or radiofrequency ablation, transarterial
chemoembolization, or liver transplantation. Patients
w i t has i n g l eH C Cn o d u l ec a n be treated by surgical
resection provided that this procedure is technically fea-
sible, that the Child-Pugh stage is A, that the serum
total bilirubin level is normal, that there is no vascular
invasion and that the hepatic venous pressure gradient
(HVPG) is 10 mmHg or less [4]. For the evaluation of
these preoperative conditions, precise imaging techni-
ques like abdominal ultrasonography, spiral computer
tomography and magnetic resonance imaging are cur-
rently widely used and provide excellent results [5]. The
measurement of the free and wedged hepatic pressure
through the transjugular route represents the gold stan-
dard method [6] to assess portal pressure and to decide
whether a liver resection is possible [4].
Although surgical resection is the mainstay of curative
treatment for HCC, long-term survival remains unsatis-
factory, because tumor recurrence is the main cause of
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include the presence of satellite nodules and vascular
invasion [8]. The currently available imaging techniques
(CT-scan, magnetic resonance imaging and external
ultrasound) can hardly diagnose small HCC and reach a
sensitivity not better than 64% for lesions of less than
10 mm in diameter [9]. The availability of imaging tech-
niques that may identify minor satellite lesions and inva-
sion of small diameter vessels would improve the
preoperative assessment of early HCC.
For these reasons, percutaneous transvenous ultra-
sound may represent a complementary novel technique
for the assessment of HCC. So far this technique has
been used only for intracardiac echography (ICE), useful
during electrophysiological mapping and ablation proce-
dures for guiding interatrial septal puncture, and for the
positioning of closure devices in patients with atrial sep-
tal defects [10,11]. The use of ICE through the hepatic
veins allows to assess the anatomy of the liver parench-
yma and the vessels and to evaluate the vascular flow by
using the Doppler technique. ICE has never been
reported for the imaging of the cirrhotic liver and HCC.
Consequently, the aim of this pilot study was to inves-
tigate the feasibility and safety of this procedure and to
evaluate the quality of images that can be obtained with
this technique.
Methods
Cirrhotic patients addressed to the gastroenterology and
hepatology division for the diagnostic work-up of
suspected or proven HCC on other imaging techniques
were eligible for this study. Transjugular liver biopsy
and hepatic hemodynamic measurements were part of
this work-up. Participants received a light sedation with
25 mg of meperidine intravenously.
Under sterile conditions, the right internal jugular vein
was catheterized under local anesthesia (1% lidocaine)
using the Seldinger technique and a 9 French introducer
(Maxxim Medical, Europe) was inserted. All procedures
were then performed under radiologic guidance using a
C-arm X-ray amplifier and controlled by conventional
abdominal ultrasound (Figure 1). Hemodynamic mea-
surements in the right or middle hepatic veins were per-
formed by using a 8 French curved catheter (Cordis,
Europe) in free and wedged position connected to a
pressure transducer. Thereafter, liver biopsy was per-
formed according to a standardized protocol. Clinical
vital data including systemic arterial pressure, pulse rate,
and oxygen saturation were monitored throughout the
procedure.
Next, the single-use intracardiac echography catheter
(AcuNav 8 F, 5.5-10 MHz, Acuson) was introduced in
sterile conditions in the hepatic veins under fluoroscopic
control. The AcuNav catheter tip was steered by the
operator into the chosen direction by external control
knobs. The middle and right hepatic veins were cathe-
terized in each case and the position of the device was
also verified by transabdominal external ultrasound.
The intracardiac echography catheter was then rotated
clock- and anti-clockwise to obtain a 360-degree view
Figure 1 Imaging of the liver by intrahepatic use of an intracardiac echography catheter (ICE). The position of the ICE catheter, here in
the right hepatic vein, was assessed by conventional X-ray (left panel, white arrow) and by conventional abdominal ultrasound (right panel,
white arrow).
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7.5 MHz for all images and the depth of liver parench-
yma explored was adjusted for maximal resolution. The
signals from the longitudinal side-fire imaging plane
were visualized and recorded using an Acuson Sequoia
C512 echocardiography platform. Vessels, parenchyma
and possible lesions were also studied using color Dop-
pler mode signals.
At the end of the procedure the catheter and the
introducer were withdrawn and the puncture site was
briefly compressed for hemostasis. Patients were then
asked about pain, discomfort or other subjective pro-
blems that occurred during this procedure.
Because this was a pilot study, at the time of ICE the
investigators were not blinded to the presence and loca-
lization of hepatic focal lesions identified by 3-phase
CT-scan or magnetic resonance imaging.
The study protocol was approved by the committee of
the University Hospitals of Geneva (protocol approval
number 07-063) and patients gave their written consent
for the participation in this study.
Results
We report here the data from intravascular ultrasound
examinations in 5 patients with hepatocellular carci-
noma using the intracardiac echographic technique. The
main clinical characteristics of these patients are pre-
sented in Table 1.
The insertion of the ICE catheter was possible into the
right and middle, but not into the left hepatic vein. The
parenchyma of the right hepatic lobe was entirely visua-
lized using ICE from the right or middle liver vein.
Depending on the anatomy of each single case, parts of
the left lobe could also be visualized from the middle
hepatic artery. The right lobe of the liver was extensively
visualized in all patients and the study of the parenchy-
mal structure and of focal lesions was performed also
with the use of color Doppler imaging. The relationship
of focal lesions to vascular structures (portal vein,
hepatic vein and artery) and to major bile ducts was
mapped. Finally, the gallbladder and the presence of
ascites were also investigated.
Liver vasculature was studied by ICE with the catheter
tip inserted in the middle or the right hepatic vein.
After adequate positioning, the hepatic artery or one of
its branches was visualized and the flow was assessed
using Doppler ultrasound in M-mode (7.5 MHz, peak
flow 80 cm/s). Similarly, the portal vein and its branches
(7.5 MHz, flow 15 cm/s), as well as the adjacent hepatic
veins (7.5 MHz, variable flow) were studied using the
same technique (Figure 2).
A selection of lesions that were identified in this study
is presented in Figure 3 and data on single procedures
and major findings are reported in Table 2. Additional
images representing multiple macroscopic focal lesions
are shown in Figure 4. All images were obtained with a
frequency of the device of 7.5 MHz.
The procedure of ICE was well tolerated and painless
in all patients and the hemodynamic parameters
remained stable during the entire intervention. There
were no medical or technical complications during or
after hepatic ICE. The catheterization of the right and
middle hepatic vein was possible in all patients. Mostly
due to unfavorable angle conditions and small dia-
meter, ICE in the left hepatic vein was technically not
possible.
Ascites was diagnosed in 3 of the 5 patients. Figure 5
shows an example of ascitic fluid collection in a patient
with micro-nodular cirrhosis as suggested by the irregu-
lar liver surface.
The mean duration of this procedure was 44 minutes
from the insertion to the extraction of the catheter.
Discussion
This pilot study demonstrates the feasibility and safety
of ICE for the evaluation of parenchymal alterations in
patients with liver cirrhosis and suspected or proven
hepatocellular carcinoma.
Table 1 Patients’ characteristics
Patient Age
(Y)
Gender Etiology of
chronic liver
disease
Child-Pugh
score (points)
Fibrosis score
(METAVIR)
MELD
score
Clinical symptoms FHVP
(mmHg)
WHVP
(mmHg)
HVPG
(mmHg)
1 44 M HBV+HCV 9 F4 14 Ascites, jaundice, fluctuant
encephalopathy
92 9 2 0
2 67 M HCV 6 F4 8 No liver decompensation 6 18 12
3 54 F HBV 6 F1 8 No liver decompensation,
severe malnutrition
594
4 42 M HBV+ Alcohol 11 F4 19 Ascites, jaundice, fluctuant
encephalopathy
11 30 19
5 72 M Alcohol 8 F4 11 Ascites and peripheral
edema
10 28 18
Abbreviations: HBV, HCV (Hepatitis virus B, C); MELD (Model of end stage liver disease); FHVP (Free hepatic venous pressure); WHVP (Wedge hepatic venous
pressure); HVPG (Hepatic venous pressure gradient)
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but not in angiology and cardiology, where this tool is
frequently used to guide non-surgical interventional pro-
cedures and to assess vascular disease [12,13]. High-
resolution portal vein imaging has been the objective of
a number of studies for evaluating possible invasion of
the venous wall by pancreatic or ampullary cancers
[14,15]. In other studies the liver has been investigated
using intravascular ultrasound from the vena cava to
guide the placement of direct intrahepatic porto-caval
Figure 3 Endovascular ultrasound view of focal lesions in a cirrhotic liver. With high resolution the visualization of small sized nodules
(diameter 0.82 cm, left panel, and 1.14 cm, central panel) was possible. The right panel shows a larger hypoechogenic lesion located in the sub-
capsular region of a multinodular liver. Arrows indicate in each case the described lesions.
Figure 2 Doppler imaging of the liver vasculature by intrahepatic use of an intracardiac echography catheter (ICE). The panel on the
left shows the typical arterial wave (in this case corresponding to the right hepatic artery). The central panel corresponds to the right branch of
the portal vein characterized by a continuous blood flow. The right panel illustrates the typical modulated flow of hepatic veins in the proximity
of the confluence into the vena cava.
Table 2 Intravascular hepatic ultrasound characteristics
Patient Duration (min) Main findings Complications
1 40 Heterogeneous hepatic parenchyma with nodular aspect none
2 55 Single liver nodule, ascites none
3 45 Multinodular aspect none
4 45 Heterogeneous aspect of parenchyma, ascites none
5 35 Hypovascular nodule in segment VII, ascites none
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However, studies aimed at examining liver parenchymal
structure and lesions, as well as portal vein branches
and hepatic veins are lacking. In this respect the present
study is the first report on the use of this technique.
Beside the assessment of the feasibility and the safety,
we also examined the imaging quality performance of
ICE. By inserting the ICE catheter into the right and
middle hepatic veins it was possible to visualize not only
liver parenchyma, focal lesions and vascular features,
AB
CD
EF
Figure 4 Examples of focal lesions identified by ICE in patients with liver cirrhosis. Without contrast medium for ultrasound, these tumors,
which were highly suspect for hepatocellular carcinoma, could not be differentiated from regenerative nodules. The ultrasound device was
introduced into the right or middle hepatic vein and the parenchyma surrounding the vessel was inspected over 360 degrees by turning the
ultrasound catheter clock- and anti-clockwise. The ultrasound pattern of these lesions was homogeneous (A, B and C) or heterogeneous (D, E
and F). No vascular invasion was identified in this study.
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and the peritoneal cavity to assess the presence of
ascites. Due to the specific left hepatic vein anatomy
a n dt h es i z eo ft h eI C Ec a t h e t e r ,w ew e r en o ta b l et o
place the catheter into the left hepatic vein in order to
obtain accurate images from this vessel. The failure to
access the left hepatic vein represents an important lim-
itation in cirrhotic patients, because a complete evalua-
tion of the liver is essential for treatment planning. The
use of ICE did however not present any other technical
drawbacks.
At the end of the procedure patients were asked about
the comfort and tolerability of ICE. The procedures
were well tolerated, as demonstrated by the absence of
pain and the hemodynamic stability throughout the pro-
cedure. It must be stressed however that we performed
ICE as a complementary investigation following the
measurement of HVPG. Hence, the invasiveness of ICE
itself was possibly under estimated by the patients. The
duration of ICE also represented a negative aspect,
because it prolonged the patient’s stay in the examina-
tion room. Finally, an additional radiation dose was used
to guide and to verify the ultrasound catheter position.
This supplementary irradiation might be avoidable in
further studies by using conventional external ultra-
sound of the liver to follow the ICE device progression
in the hepatic veins.
The performance of ICE in detecting nodules and
visualizing blood vessels was tested qualitatively by com-
paring its findings with those obtained by using other
imaging techniques such as CT or MRI in the same
patients. Although the number of patients was small
and the study was not designed to assess this endpoint,
ICE findings were similar to those observed on images
obtained by CT or MRI in the right hepatic lobe.
Future studies of ICE should assess the qualitative
performance of this technique as a complement to
external ultrasound, CT scan and magnetic resonance
imaging for the evaluation of satellite small lesions and
vascular invasion and/or thrombosis. Nevertheless,
these results need first to be replicated in a larger
number of patients before being translated into clinical
strategies.
An additional point to be considered is the cost of this
device, which is approximately 2500 Euros at this time.
ICE catheters are for single use and their use must be
accurately evaluated and be limited to clinical studies
only. Besides diagnostic procedures, this technique
might also be evaluated for interventional purposes, for
example to assess the placement of transjugular intrahe-
patic porto-systemic shunts.
Conclusions
This study demonstrated that a diagnostic approach using
an ICE device is feasible in the right and middle hepatic
veins, safe and well tolerated. However, it remains for the
moment only an experimental investigative tool. This
technique has the potential of an increased resolution
power to image infra-centimetric vascular invasion.
Whether ICE, as compared to other imaging techniques,
could provide clinically relevant information in patients
with parenchymal lesions and associated vascular altera-
tions needs additional investigation.
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Figure 5 Ascites in moderate quantity was visualized from the
hepatic vein by intracardiac ultrasound technique. The presence
of an irregular hepatic border suggests nodular reorganization of
the hepatic parenchyma as seen in cirrhosis.
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